The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis Study
NCT05820698 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2025-05-04
Summary
The METRED-P study will test the feasibility of implementing a Mediterranean style diet and/or time-restricted eating as dietary patterns in individuals with psoriasis. This study will address the following research questions:
1. Are participants' able to adhere to the allocated dietary intervention?
2. What is the participants' acceptability of the allocated dietary intervention?
3. What is the practicality (from a clinician's stand point) of delivering the dietary interventions?
4. When adhering to the allocated intervention, are there changes in psoriasis severity?
5. When adhering to the allocated intervention, are there changes in measures of body composition?
6. When adhering to the allocated intervention, are there changes in fasting blood measures?
Participants will attend an initial clinic visit for a fasting blood sample, psoriasis examination, body composition measurements, and will complete short multiple-choice questionnaires on the severity of their psoriasis. A Research Nutritionist will deliver the diet interventions as diet consultation sessions. These sessions are reoccurring throughout the study as virtual consultation booster sessions, which are supplemented with wellbeing check-in calls. Participants will complete short questionnaires on the severity of their psoriasis and will record their dietary intake for 4 days, before the start of the study, and on week 1, week 6, and week 12 of the study. The allocated diet should be adhered to for 12 weeks until the end of the study, where participants will return and attend a final clinic visit to repeat the measures obtained during the initial clinic visit.
Researchers will compare the feasibility of implementing a Mediterranean style diet and a Mediterranean style diet with time-restricted eating, with a UK diet with time-restricted eating.
Conditions
- Psoriasis Vulgaris
Interventions
- OTHER
-
Time-restricted eating
Participants randomised to the time-restricted eating interventions will be advised to limit food intake to a 10-hour eating window and to abstain from food intake for a 14-hour fasting window. Hydration is to be maintained during the fasting window with water and/or plain teas/coffees
- OTHER
-
The Mediterranean style diet
Participants in the Mediterranean style diet group will be provided with recommendations to include a minimum of 5 servings of fruits and vegetables (combined) per day, 2 servings of whole grains per meal per day, at least two servings of extra virgin olive oil per day, a maximum two servings of dairy products per day (excluding milk in coffee/tea), a minimum of 3 servings of fish per week (of which two should be oily fish), less than 2 servings of red meat or processed meat per week. Confectionary and sugar sweetened beverages should be limited to less than 2 servings per week. Participants randomised to the Mediterranean style intervention will be provided with support documents including a dietary guideline booklet, recipes, meal plans, shopping and product swap lists, as well as eating-out and budget-eating advice sheets. Food deliveries containing key food items of the diet intervention will be scheduled for week 1, week 4, and week 8 of the study.
- OTHER
-
The UK diet
Participants in the UK diet with time-restricted eating group will be provided with recommendations of a nutritionally balanced diet, corresponding to the average intakes of the UK population. Participants will be advised to consume no more than 4 portions of fruits and vegetables combined per day, to have at least two servings of dairy per day, to limit the consumption of white fish to less than 1 serving per week, with ≤1 serving of oily fish per month. Nuts and seeds consumption should also be limited to ≤1 serving per week and at least 3 servings of white and red meat should be consumed per week. Participants randomised to the UK diet will be provided with support documents including a dietary guideline booklet, recipes, and meal plans. A £30 reimbursement will be provided to participants for their grocery shopping on week 1, week 4, and week 8 of the study.
Sponsors & Collaborators
-
Psoriasis Association
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Wendy L Hall, PhD · Reader in Nutritional Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-08
- Primary Completion
- 2024-10-02
- Completion
- 2024-10-02
Countries
- United Kingdom
Study Locations
More Related Trials
-
Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)
NCT06905028 ·Status: RECRUITING ·Phase: NA
-
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
NCT03791216 ·Status: COMPLETED
-
Dietary Perceptions and Practices in Chinese Psoriasis Patients
NCT05118425 ·Status: COMPLETED
-
Modified Intermittent Fasting in Psoriasis
NCT04418791 ·Status: COMPLETED ·Phase: NA
-
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
NCT00477191 ·Status: TERMINATED ·Phase: NA
-
Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
NCT00537212 ·Status: COMPLETED ·Phase: NA
-
A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis
NCT02382081 ·Status: COMPLETED ·Phase: NA
-
Dietary Approach to Mild-to-moderate Psoriasis
NCT05644782 ·Status: RECRUITING ·Phase: NA
-
Effect of Weight Loss on Psoriasis
NCT01137188 ·Status: COMPLETED ·Phase: NA
-
Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis
NCT05590247 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis
NCT03597620 ·Status: COMPLETED ·Phase: PHASE4
-
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
NCT02193919 ·Status: COMPLETED
-
Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)
NCT02902861 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis
NCT02271971 ·Status: COMPLETED ·Phase: NA
-
Study of CRx-191 to Assess Activity in Plaque Psoriasis
NCT00557739 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
NCT01019200 ·Status: COMPLETED
-
Peds Metabolic Syndrome in Psoriasis
NCT00930592 ·Status: COMPLETED
-
The Role of Food Sensitivity in Psoriasis
NCT03084146 ·Status: COMPLETED ·Phase: NA
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis
NCT01714284 ·Status: COMPLETED ·Phase: NA
-
This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
NCT03802344 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels
NCT03932110 ·Status: COMPLETED ·Phase: NA
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
NCT01947491 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of COVID 19 on Psoriasis Patients
NCT05381402 ·Status: UNKNOWN